The plain-language read
Harmonization through international testing standards has improved comparability of sunscreen efficacy, although regulatory diversity continues to pose challenges for global implementation. Integrating scientific evidence with existing region-specific regulatory requirements is essential for effective photoprotection, informed sunscreen use, and improved public health outcomes.
- Integrating scientific evidence with existing region-specific regulatory requirements is essential for effective photoprotection, informed sunscreen use, and improved public health outcomes.
- Harmonization through international testing standards has improved comparability of sunscreen efficacy, although regulatory diversity continues to pose challenges for global implementation.
Relevant if you're working with urea, pha for aging and rosacea.
What this means for your routine
If you're targeting aging, this research supports adding urea to your AM/PM routine.
If you're targeting aging, this research supports adding pha to your AM/PM routine.
Translated from this study's findings, not a personal prescription. Pair with your existing protocol and your practitioner's guidance.
Technical Summary, For Professional Reference
Clinical context
1. Cureus. 2026 Feb 17;18(2):e103757. doi: 10.7759/cureus.103757. eCollection 2026 Feb. Global Perspectives on Regional Sun Protection Factor (SPF) Requirements: Scientific and Regulatory Insights. Patel MN(1)(2), Patel N(1).
Full abstract→
1. Cureus. 2026 Feb 17;18(2):e103757. doi: 10.7759/cureus.103757. eCollection 2026 Feb. Global Perspectives on Regional Sun Protection Factor (SPF) Requirements: Scientific and Regulatory Insights. Patel MN(1)(2), Patel N(1). Author information: (1)Clinical Research Operations, NovoBliss Research Private Limited, Ahmedabad, IND. (2)Pharmacology, Swaminarayan University, Ahmedabad, IND. Ultraviolet (UV) radiation is a well-established environmental factor contributing to acute and chronic skin damage, including erythema, photoaging, pigmentary disorders, and skin cancer. Sunscreens represent a cornerstone of photoprotection strategies, with sun protection factor (SPF) serving as the primary measure of protection against UVB-induced erythema. However, UV exposure varies considerably across geographic regions due to differences in latitude, climate, altitude, and lifestyle, necessitating region-specific SPF recommendations. In parallel, sunscreen regulation and SPF claim substantiation differ across global jurisdictions, influencing product development, labeling, and consumer communication. This scientific communication reviews the biological basis of UV-induced skin damage, the rationale for region-wise SPF selection, and the regulatory frameworks governing sunscreen efficacy and claims across major global authorities, including India (Bureau of Indian Standards (BIS)), the European Union (EU; European Cosmetic, Toiletry and Perfumery Association (COLIPA)), the United States (Food and Drug Administration (FDA)), Australia (Therapeutic Goods Administration (TGA)), Canada (Health Canada), and Japan (Ministry of Health, Labour and Welfare (MHLW)/Japan Cosmetic Industry Association (JCIA)). While regulatory approaches differ in classification, UVA assessment methodologies, and labeling systems, there is a shared scientific consensus on the importance of validated SPF testing, broad-spectrum protection, and responsible communication. Harmonization through international testing standards has improved comparability of sunscreen efficacy, although regulatory diversity continues to pose challenges for global implementation. Integrating scientific evidence with existing region-specific regulatory requirements is essential for effective photoprotection, informed sunscreen use, and improved public health outcomes. Copyright © 2026, Patel et al. DOI: 10.7759/cureus.103757 PMCID: PMC13000865 PMID: 41869094 Conflict of interest statement: Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Original source →Does Astragalus mongholicus Bunge help promote the healing of wounds? A systematic review and meta-analysis of preclinical animal studies.
Wounds continue to represent a significant public health challenge globally. In recent years, Astragalus mongholicus Bunge, a traditional Chinese botanical drug utilized for wound treatment, has garnered increasing research attention. However, the therapeutic efficacy and safety of this natural botanical drug on wound healing remain poorly understood.
Safety and efficacy of individualised exercise and NAD(+) precursor supplementation in patients with Friedreich's ataxia in the USA: a single-centre, 2 × 2 factorial, randomised controlled trial.
Friedreich's ataxia is a rare, chronic, progressive, neurodegenerative condition affecting multiple organ systems, including neurological, musculoskeletal, cardiac, and endocrine systems, and is marked by low cardiopulmonary fitness. We tested the effect of exercise and NAD+ precursor supplementation with nicotinamide riboside, which have each shown benefits in animal and early clinical studies, on cardiopulmonary fitness in individuals with Friedreich's ataxia. This 12-week, outpatient, phase 2, single-site (Children's Hospital of Philadelphia, Philadelphia, PA, USA), randomised, 2 × 2 factorial clinical trial recruited individuals aged 10-40 years with an ejection fraction of 45% or greater who were able to exercise.
Multitargeted Modulation of Skin Dullness by HNHT Formulation: Synergistic Inhibition of Melanogenesis, Glycation, and Lipofuscin Deposition.
Skin dullness, characterized by pigmentation disorders and yellowing, is a major cosmetic concern in Asian populations. Lipofuscin exhibits ultraviolet (UV)/visible light spectral absorption, reduces skin reflectance, and contributes to dullness, whereas existing therapies targeting melanogenesis and glycation lack comprehensive efficacy. This study aimed to evaluate the multimodal anti-dullness effects of a novel formulation (HNHT: hyaluronic acid, niacinamide, hydrolyzed red algae, and tranexamic acid).